Oruka Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $46.9M | $61.6M | $37.4M | $42.4M | $53.4M | $49.1M | $8.4M | $6.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $343.9M | $376.9M | $37.6M | $42.7M | $54.4M | $50.0M | $8.5M | $6.8M |
| Property, Plant & Equipment | $288.0K | $162.0K | $10.0K | $25.0K | $48.0K | $21.0K | $10.0K | $24.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $488.6M | $396.0M | $37.9M | $43.1M | $54.9M | $50.4M | $8.5M | $6.8M |
| Liabilities | ||||||||
| Accounts Payable | $4.2M | $3.5M | $362.0K | $334.0K | $1.1M | $1.8M | $418.0K | $230.0K |
| Total Current Liabilities | $15.4M | $13.0M | $637.0K | $1.1M | $3.5M | $3.5M | $926.0K | $793.0K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $16.7M | $13.8M | $841.0K | $1.4M | $3.9M | $3.9M | $926.0K | $793.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-189.2M | $-83.7M | $-188.7M | $-183.4M | $-173.5M | $-154.2M | $-144.4M | $-138.9M |
| Total Stockholders' Equity | $471.9M | $382.2M | $37.0M | $41.7M | $51.0M | $46.5M | $7.6M | $6.0M |